Cargando…
Progression of Cardiovascular Manifestations in Adults and Children With Mucopolysaccharidoses With and Without Enzyme Replacement Therapy
Background: Cardiovascular involvement is among the main features of MPS disorders and it is also a significant cause of morbidity and mortality. The range of manifestations includes cardiac valve disease, conduction abnormalities, left ventricular hypertrophy, and coronary artery disease. Here, we...
Autores principales: | Poswar, Fabiano de Oliveira, Santos, Hallana Souza, Santos, Angela Barreto Santiago, Berger, Solano Vinicius, de Souza, Carolina Fischinger Moura, Giugliani, Roberto, Baldo, Guilherme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790121/ https://www.ncbi.nlm.nih.gov/pubmed/35097020 http://dx.doi.org/10.3389/fcvm.2021.801147 |
Ejemplares similares
-
Diagnosis of Mucopolysaccharidoses
por: Kubaski, Francyne, et al.
Publicado: (2020) -
Precision Medicine for Lysosomal Disorders
por: Pinto e Vairo, Filippo, et al.
Publicado: (2020) -
Lysosomal diseases: Overview on current diagnosis and
treatment
por: Poswar, Fabiano de Oliveira, et al.
Publicado: (2019) -
Enzyme replacement therapy interruption in patients with Mucopolysaccharidoses: Recommendations for distinct scenarios in Latin America
por: Solano, MarthaL., et al.
Publicado: (2020) -
Mucopolysaccharidoses in northern Brazil: Targeted mutation screening and urinary glycosaminoglycan excretion in patients undergoing enzyme replacement therapy
por: Viana, Gustavo M., et al.
Publicado: (2011)